Metasphere Labs Announces Amended and Restated LIFE Offering Document

Executive Summary

• Metasphere Labs Inc. announces an amendment to its previously disclosed listed issuer financing exemption, now offering up to 5 million units at $0.09 per unit for gross proceeds of up to $450,000.
• Each unit consists of one common share and one transferable warrant allowing purchase of an additional share at $0.12 after a 61‑day lock‑up, exercisable for four years.
• The company cancels the previously announced concurrent non‑LIFE offering and expects the proceeds to fund general working capital and support operations for the next 12 months.

Key Details

• Offering Size: Up to 5,000,000 units
• Price per Unit: $0.09
• Gross Proceeds Target: Up to $450,000
• Unit Composition:
• 1 common share of Metasphere Labs Inc.
• 1 transferable common share purchase warrant (exercise price $0.12)
• Warrant Terms: Exercisable any time on or after 61 days post‑closing; valid for four years from the closing date.
• Closing Timeline: Expected to close on or about December 1, 2025 (subject to change).
• Regulatory Basis: Offered under the Listed Issuer Financing Offering exemption (NI 45‑106 section 5A.2) and Coordinated Blanket Order 45‑935.
• Use of Proceeds: General working capital and other purposes described in the offering document.
• Cancellation Notice: The previously announced non‑LIFE offering is cancelled.
• Future Financing Outlook: Company may consider additional financing (e.g., private placements) to accelerate product development or enhance liquidity, though not required for operations over the next 12 months.

Notable Quotes

(No direct CEO/President quotes were included in the release.)